DISHMAN CARBOGEN AMCIS
Back to Income Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,616 Cr | ₹2,413 Cr | ₹2,141 Cr | ₹1,912 Cr | ₹2,044 Cr |
What is the latest Revenue of DISHMAN CARBOGEN AMCIS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,616 Cr |
| Mar2024 | ₹2,413 Cr |
| Mar2023 | ₹2,141 Cr |
| Mar2022 | ₹1,912 Cr |
| Mar2021 | ₹2,044 Cr |
How is Revenue of DISHMAN CARBOGEN AMCIS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,616 Cr | 8.41 | |
| Mar2024 | ₹2,413 Cr | 12.72 | |
| Mar2023 | ₹2,141 Cr | 11.96 | |
| Mar2022 | ₹1,912 Cr | -6.44 | |
| Mar2021 | ₹2,044 Cr | - | |
Compare Revenue of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,673.4 Cr | -0.2% | -15% | -27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -0.2% |
-15% |
-27.8% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses